XBiotech (XBIT) News Today $3.03 -0.02 (-0.66%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$3.26 +0.23 (+7.59%) As of 07/8/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period XBiotech (NASDAQ:XBIT) Share Price Crosses Above 50-Day Moving Average - Here's WhyJuly 4, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Share Price Crosses Below 50 Day Moving Average - Here's WhyJune 26, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Stock Price Crosses Below 50-Day Moving Average - Here's WhyJune 14, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Share Price Crosses Below 50-Day Moving Average - What's Next?May 25, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Stock Crosses Below 50 Day Moving Average - What's Next?May 17, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Share Price Crosses Below 50-Day Moving Average - Time to Sell?May 2, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Share Price Crosses Below 50-Day Moving Average - Should You Sell?April 24, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Share Price Passes Above 50 Day Moving Average - Here's What HappenedApril 11, 2025 | marketbeat.comXBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in MarchMarch 31, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Shares Pass Above Fifty Day Moving Average - Here's What HappenedMarch 26, 2025 | marketbeat.comXBiotech (NASDAQ:XBIT) Releases Quarterly Earnings ResultsMarch 19, 2025 | marketbeat.comXBiotech Inc. (NASDAQ:XBIT) Sees Large Growth in Short InterestFebruary 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBITFebruary 4, 2025 | prnewswire.comXBiotech stock hits 52-week low at $3.5 amid market challengesJanuary 28, 2025 | msn.comXBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law FirmJanuary 17, 2025 | prnewswire.comWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities lawsJanuary 14, 2025 | globenewswire.comXBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law FirmJanuary 13, 2025 | businesswire.comXBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35%January 10, 2025 | finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBITJanuary 8, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBITJanuary 2, 2025 | prnewswire.comXBiotech Appoints Renowned Scientist to Board of DirectorsDecember 31, 2024 | tipranks.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBITDecember 27, 2024 | prnewswire.comXBiotech trading halted, news pendingDecember 25, 2024 | markets.businessinsider.comXBiotech halts all rheumatology research after missing Phase II endpointsDecember 25, 2024 | msn.comXBiotech Inc.: XBiotech Pauses Rheumatology programDecember 23, 2024 | finanznachrichten.deXBiotech Halts Rheumatology Clinical ProgramDecember 23, 2024 | marketwatch.comXbiotech Shares Hit 52-Week Low on Halted Rheumatology ProgramDecember 23, 2024 | marketwatch.comXBiotech Pauses Rheumatology programDecember 23, 2024 | globenewswire.comXBiotech (NASDAQ:XBIT) Share Price Passes Below Fifty Day Moving Average - Here's What HappenedNovember 19, 2024 | marketbeat.comXBiotech (NASDAQ:XBIT) Share Price Crosses Above 50 Day Moving Average - Time to Sell?November 8, 2024 | marketbeat.comXBiotech (NASDAQ:XBIT) Shares Cross Above 50-Day Moving Average - Time to Sell?October 31, 2024 | marketbeat.comXBiotech (NASDAQ:XBIT) Stock Price Passes Above 50-Day Moving Average - Time to Sell?October 23, 2024 | marketbeat.comXBiotech (NASDAQ:XBIT) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.com76,460 Shares in XBiotech Inc. (NASDAQ:XBIT) Acquired by American Century Companies Inc.October 4, 2024 | marketbeat.comXBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.22August 14, 2024 | marketbeat.comXBIT Stock Earnings: XBiotech Reported Results for Q2 2024August 12, 2024 | investorplace.comXBiotech Inc. (NASDAQ:XBIT) most popular amongst retail investors who own 51%, insiders hold 35%August 3, 2024 | finance.yahoo.comXBiotech (NASDAQ:XBIT) Stock Crosses Above 50 Day Moving Average of $6.35August 3, 2024 | marketbeat.comXBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short InterestJuly 26, 2024 | marketbeat.comXBiotech Inc. (NASDAQ:XBIT) Sees Large Decrease in Short InterestJuly 14, 2024 | marketbeat.comXBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic CancerJune 18, 2024 | globenewswire.comXBiotech Inc. (XBIT)May 25, 2024 | finance.yahoo.comXBiotech: Several Shots On Goal In Big Target Market IndicationsMay 24, 2024 | seekingalpha.comXBIT Stock Earnings: XBiotech Reported Results for Q1 2024May 13, 2024 | investorplace.comXBiotech Inc. (XBIT) Stock Price, News, Quote & History - Yahoo FinanceApril 25, 2024 | finance.yahoo.comXBiotech IncApril 24, 2024 | money.usnews.comXBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insidersMarch 20, 2024 | finance.yahoo.comXBIT Stock Earnings: XBiotech Reported Results for Q4 2023March 18, 2024 | investorplace.comXBiotech Inc. (NASDAQ:XBIT) Short Interest Up 35.4% in FebruaryMarch 14, 2024 | marketbeat.comThe Zacks Analyst Blog Highlights Quince Therapeutics and XBiotechMarch 8, 2024 | finance.yahoo.com Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address XBIT Media Mentions By Week XBIT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XBIT News Sentiment▼0.590.57▲Average Medical News Sentiment XBIT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XBIT Articles This Week▼10▲XBIT Articles Average Week Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TERN News Today HUMA News Today PRTA News Today HRTX News Today AMRN News Today PRME News Today SNDL News Today AQST News Today CTOR News Today OLMA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XBIT) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.